logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Masahiro Morise

Nagoya University
H指数:28
被引数:7,400

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Favorable clinical impact of histological subtype with non-small cell carcinoma-not otherwise specified in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

非小细胞肺癌患者接受免疫检查点抑制剂治疗时，组织学亚型对非小细胞癌（未特指）的积极临床影响

Respiratory Investigation
IF2
2026-02-010
OAAI
Hirano, Tatsuya; Tanaka, Ichidai; Morise, Masahiro; Koyama, Junji; Hashimoto, Takahiko; Hori, Kazumi; Matsuzawa, Reiko; Hori, Sho; Karube, Kennosuke; Ito, Takayasu; Sakamoto, Koji; Shindo, Yuichiro; Sato, Mitsuo; Yokoyama, Toshihiko; Kimura, Tomoki; Kondoh, Yasuhiro; Ishii, Makoto
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib

小细胞肺癌(SCLC)前瞻性大规模基因组筛查的临床意义：遗传分类及Gedatolisib生物标志物驱动的II期试验

JOURNAL OF THORACIC ONCOLOGY
IF20.8
2025-02-014
PRE
Umemura, Shigeki; Udagawa, Hibiki; Ikeda, Takaya; Murakami, Haruyasu; Daga, Haruko; Toyozawa, Ryo; Kozuki, Toshiyuki; Sakakibara-Konishi, Jun; Ohe, Yuichiro; Morise, Masahiro; Kato, Terufumi; Shingyoji, Masato; Hara, Satoshi; Furuya, Naoki; Takata, Saori; Miyamoto, Shingo; Nakachi, Ichiro; Wakabayashi, Masashi; Nomura, Shogo; Sato, Akihiro; Ishii, Genichiro; Tsuchihara, Katsuya; Sugiyama, Eri; Kirita, Keisuke; Sakai, Tetsuya; Shibata, Yuji; Izumi, Hiroki; Nosaki, Kaname; Zenke, Yoshitaka; Matsumoto, Shingo; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION

特波替尼在MET外显子14跳跃的亚洲晚期NSCLC患者中的疗效和安全性

BRITISH JOURNAL OF CANCER
IF6.8
2024-04-040
OA
Kato, Terufumi; Yang, James Chih-Hsin; Ahn, Myung-Ju; Sakai, Hiroshi; Morise, Masahiro; Chen, Yuh-Min; Han, Ji-Youn; Yang, Jin-Ji; Zhao, Jun; Hsia, Te-Chun; Berghoff, Karin; Bruns, Rolf; Vioix, Helene; Lang, Simone; Johne, Andreas; Le, Xiuning; Paik, Paul K.
Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial

非小细胞肺癌 (SCORPION) 一线铂类化疗加免疫检查点抑制剂后多西他赛加雷莫昔单抗二线治疗的疗效和安全性: 一项多中心、开放标签、单臂、2期临床试验

ECLINICALMEDICINE
IF10
2023-12-014
OAAI
Matsuzawa, Reiko; Morise, Masahiro; Ito, Kentaro; Hataji, Osamu; Takahashi, Kosuke; Koyama, Junji; Kuwatsuka, Yachiyo; Imaizumi, Kazuyoshi; Goto, Yasuhiro; Itani, Hidetoshi; Yamaguchi, Teppei; Zenke, Yoshitaka; Oki, Masahide; Ishii, Makoto
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
2022-08-0313
OA
Kobayashi, Tomoko; Iwama, Shintaro; Yamagami, Ayana; Yasuda, Yoshinori; Okuji, Takayuki; Ito, Masaaki; Zhou, Xin; Ando, Masahiko; Onoue, Takeshi; Miyata, Takashi; Sugiyama, Mariko; Hagiwara, Daisuke; Suga, Hidetaka; Banno, Ryoichi; Hase, Tetsunari; Morise, Masahiro; Ito, Takanori; Kikumori, Toyone; Inoue, Megumi; Ando, Yuichi; Masuda, Norikazu; Kawashima, Hiroki; Hashimoto, Naozumi; Arima, Hiroshi
CLIP1-LTK: a novel target in non-small cell lung cancer
ANNALS OF ONCOLOGY
IF65.4
2022-07-010
OAAI
Izumi, Hiroki; Matsumoto, Shingo; Mori, Shunta; Hayashi, Kumiko; Watanabe, Kana; Fukuhara, Tatsuro; Shibata, Yuji; Yoh, Kiyotaka; Morise, Masahiro; Toyozawa, Ryo; Chikamori, Kenichi; Miyamoto, Shingo; Asano, Shuichi; Shingyoji, Masato; Nakao, Mika; Azuma, Koichi; Niho, Seiji; Ishii, Genichiro; Kobayashi, S. Susumu; Goto, Koichi

研究方向

暂未获取到该数据
Y
Yoshinori Hasegawa
H 指数:63论文数:625被引数:1.5万
N
Naozumi Hashimoto
H 指数:42论文数:315被引数:7,795
T
Tetsunari Hase
H 指数:28论文数:168被引数:2,441
M
Mitsuo Sato
H 指数:48论文数:527被引数:1.1万
S
Shingo Matsumoto
H 指数:60论文数:791被引数:1.3万
X
Xiuning Le
H 指数:50论文数:470被引数:1.1万
I
Ichidai Tanaka
H 指数:17论文数:91被引数:1,529
J
Junji Koyama
H 指数:23论文数:201被引数:2,031
H
Hiroshi Sakai
H 指数:46论文数:510被引数:1.3万
T
Terufumi Kato
H 指数:58论文数:521被引数:2.9万